Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Are novel serum biomarkers informative?

Wilkins JT, Lloyd-Jones DM.

Med Clin North Am. 2012 Jan;96(1):1-11. doi: 10.1016/j.mcna.2012.01.017. Review.

PMID:
22391247
2.

What is the role of alternative biomarkers for coronary heart disease?

Garg A.

Clin Endocrinol (Oxf). 2011 Sep;75(3):289-93. doi: 10.1111/j.1365-2265.2011.04045.x.

PMID:
21521314
3.

[Biomarkers in cardiology--state of the art 2007].

Mair J.

Wien Med Wochenschr. 2007 Feb;157(3-4):48-56. Review. German.

PMID:
17340059
4.

Assessing coronary heart disease risk with traditional and novel risk factors.

Wilson PW.

Clin Cardiol. 2004 Jun;27(6 Suppl 3):III7-11. Review.

5.

Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients.

Kanwar M, Hashem M, Rosman H, Kamalakannan D, Cheema A, Ali A, Gardin J, Maciejko JJ.

Am J Cardiol. 2006 Nov 1;98(9):1283-7.

PMID:
17056347
6.

Multimarker approach to risk stratification among patients with advanced chronic heart failure.

Yin WH, Chen JW, Feng AN, Lin SJ, Young S.

Clin Cardiol. 2007 Aug;30(8):397-402.

7.

Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes.

Manenti ER, Bodanese LC, Camey SA, Polanczyk CA.

Clin Cardiol. 2006 Sep;29(9):405-10.

8.

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J.

N Engl J Med. 2008 May 15;358(20):2107-16. doi: 10.1056/NEJMoa0707064.

9.

Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.

Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H.

J Am Coll Cardiol. 2009 Aug 11;54(7):601-8. doi: 10.1016/j.jacc.2009.05.022.

10.

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.

Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH Jr, Sorlie P, Diao G, Sharrett AR.

Arch Intern Med. 2006 Jul 10;166(13):1368-73.

PMID:
16832001
11.

Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.

Eggers KM, Kempf T, Venge P, Wallentin L, Wollert KC, Lindahl B.

Am Heart J. 2010 Jul;160(1):88-94. doi: 10.1016/j.ahj.2010.05.002.

PMID:
20598977
12.

C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.

Buckley DI, Fu R, Freeman M, Rogers K, Helfand M.

Ann Intern Med. 2009 Oct 6;151(7):483-95. Review.

PMID:
19805771
13.

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E.

Circulation. 2002 Apr 16;105(15):1760-3.

15.

Influence of imprecision on ROC curve analysis for cardiac markers.

Kupchak P, Wu AH, Ghani F, Newby LK, Ohman EM, Christenson RH.

Clin Chem. 2006 Apr;52(4):752-3.

16.

Glaucoma risk factor assessment and prevention: lessons from coronary heart disease.

Girkin CA, Kannel WB, Friedman DS, Weinreb RN.

Am J Ophthalmol. 2004 Sep;138(3 Suppl):S11-8. Review.

PMID:
15364048
17.

[Study on C-reactive protein and the risk factors of traditional coronary heart disease].

Guo ZR, Hu XS, Chen FM, Wu M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Nov;28(11):1064-8. Chinese.

PMID:
18396656
18.

Screening for heart disease: C-reactive protein versus coronary artery calcium.

Patel AA, Budoff MJ.

Expert Rev Cardiovasc Ther. 2010 Jan;8(1):125-31. doi: 10.1586/erc.09.166. Review.

PMID:
20014938
19.

C-Reactive Protein and secondary prevention of coronary events.

Biasucci LM.

Clin Chim Acta. 2001 Sep 15;311(1):49-52. Review.

PMID:
11557253
20.

Supplemental Content

Support Center